跳至主要内容
临床试验/IRCT20200127046282N22
IRCT20200127046282N22尚未招募1 期

Evaluation of the efficacy and safety of autologous cell transplantation without melanocyte-keratinocyte culture in suspension and gel form in the treatment of patients with persistent vitiligo: Phase one clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Having no treatment within past 6 months
  • No pregnancy or breast-feeding
  • Have a diagnosis of vitiligo with depigmented patch more than 5 cm despite receiving at least 3 months active treatment
  • No infection at recipient site
  • No history of keloid and or koebner phenomenon
  • No history of active hepatitis the B, C, or AIDS
  • No active uncontrolled chronic systemic disease

排除标准

  • Vitiligo patients with active or progressive disease within last 12 months.

研究者

相似试验